Roundtable on Black in cancer research and oncology - presented by Dr. Brandon Blue MD and Dr. Kilan Ashad-Bishop and Drs. Onyinye and Folu Balogun and Runcie C.W. Chidebe Dip., BSc., MSc., and Kathryn Mcginnis and Dr Paraskevi Mallini and Dr. Lisa Hoffmann-Haas

Roundtable on Black in cancer research and oncology

Brandon Blue, Kilan Ashad-Bishop, Onyinye and Folu Balogun and Runcie C.W. Chidebe

Dr. Brandon Blue MDDr. Kilan Ashad-BishopDrs. Onyinye and Folu BalogunRuncie C.W. Chidebe Dip., BSc., MSc.,
Slide at 44:57
Call to Action Runcie Chidebe More than 90% of all participants in prostate cancer clinical trials are Caucasian men even when we all know that Black men represent more than 20% of prostate cancer diagnoses. World Rencsok, et al., (2020). Diversity of enrollment in prostate cancer clinical trials: current status and future directions. Cancer Epidemiology, Biomarkers & Prevention, 29(7), 1374-1380 www.projectpinkblue.org @projectpinkblue @runciecwc
1
2
3
References
  • 1.
    E. M. Rencsok et al. (2020) Diversity of Enrollment in Prostate Cancer Clinical Trials: Current Status and Future Directions. Cancer Epidemiology, Biomarkers & Prevention
  • 2.
    https://twitter.com/runciecwc
  • 3.
    https://twitter.com/projectpinkblue
Share slide
Summary (AI generated)

You know, even when we know that Black men represent 20% of prostate cancer diagnoses, there is a large inequity in the distribution of clinical trials and access to cancer treatment.